glp-1 receptor agonists for type 2 diabetes Schematic illustration of monoagonists, dual and triple GLP1 Receptor Agonists vs SGLT2-I

Support antioxidant capacity: Optimise selenium, riboflavin, and vitamin D status to support glutathione function and reduce oxidative stress

6 World Anti-Doping AgencyProhibited List peptide hormones and GH secretagogues / releasing factors (class S2)

MC1R, MC3R, MC4R, and MC5R Mapping For Melanotan II product-page context, MC1R, MC3R, MC4R, and MC5R are the most relevant receptor labels to map

Sodium-glucose co-transporters are responsible for 97% of glucose reabsorption6 and their inhibition lowers blood glucose by increasing renal glucose excretion.4 , 5 Using SGLT-2 inhibitors increases the risk of DKA6 , 7 by decreasing daily carbohydrate availability by 20%45%,9 lowering endogenous insulin production and stimulating lipolysis that leads to ketogenesis.6 Patients who also receive insulin may decrease insulin doses in response to lower blood glucose patterns, leading to insulin deficiency